Senesco Technologies: Finally In the Cancer Clinic

Last week I received an email from a Discovery reader relative to Senesco’s progress. I think these questions are relevant for all Discovery readers. My personal feeling is that because the company now has open clinical trials, the best is yet to come for cancer patients. Senesco has an open Phase 1b/2a clinical study at the Mayo Clinic, Rochester, MN, to evaluate SNS01-T, the Company’s lead therapeutic candidate for the treatment of multiple myeloma.

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]